Avacincaptad pegol, sold under the brand name Izervay, is a medication used for the treatment of age-related macular degeneration. Avacincaptad pegol is a complement inhibitor.
Avacincaptad pegol was approved for medical use in the United States in August 2023.
Medical uses Avacincaptad pegol is indicated for the treatment of geographic atrophy secondary to age-related macular degeneration.
Society and culture Avacincaptad pegol is the international nonproprietary name.
References
External links